Skip to content
Home/Companies/MedTech/Carmel Pharma

Carmel Pharma

MedTech·Sweden·Exited 2011·Held 9yr
Entry
2002
Hold
9yr
Exit
2011

Who owns Carmel Pharma?

Carmel Pharma was owned by Industrifonden through Industrifonden Evergreen (1991 vintage) from 2002 to 2011, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-17

Industrifonden
Investor
Industrifonden
Industrifonden Evergreen · 1991 · VC

Key facts

HQSweden
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2011

More from Industrifonden Evergreen

Other portfolio companies in the same fund.

Agteria Biotech
Active
AgTechSweden· 2025
Echandia
Active
ClimateTechSweden· 2025
Tribune Therapeutics
Active
BiotechSweden· 2025
Adamant Quanta
Active
Deep TechSweden· 2023
AlixLabs
Active
Deep TechSweden· 2023
HVR Cardio
Active
MedTechSweden· 2023

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Carmel Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Carmel Pharma?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Carmel Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue